Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science.

Wentzensen N, Sherman ME, Schiffman M, Wang SS.

Gynecol Oncol. 2009 Feb;112(2):293-9. doi: 10.1016/j.ygyno.2008.10.012. Epub 2008 Dec 2. Review.

PMID:
19054549
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer.

Huang TH, Lai HC, Liu HW, Lin CJ, Wang KH, Ding DC, Chu TY.

Int J Gynecol Cancer. 2010 May;20(4):513-9. doi: 10.1111/IGC.0b013e3181c7fe6e.

PMID:
20442585
[PubMed - indexed for MEDLINE]
3.

Credentialing of DNA methylation assays for human genes as diagnostic biomarkers of cervical intraepithelial neoplasia in high-risk HPV positive women.

Vasiljević N, Scibior-Bentkowska D, Brentnall AR, Cuzick J, Lorincz AT.

Gynecol Oncol. 2014 Mar;132(3):709-14. doi: 10.1016/j.ygyno.2014.02.001. Epub 2014 Feb 6.

PMID:
24508839
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Evaluation of candidate methylation markers to detect cervical neoplasia.

Shivapurkar N, Sherman ME, Stastny V, Echebiri C, Rader JS, Nayar R, Bonfiglio TA, Gazdar AF, Wang SS.

Gynecol Oncol. 2007 Dec;107(3):549-53. Epub 2007 Sep 25.

PMID:
17894941
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Sequential gene promoter methylation during HPV-induced cervical carcinogenesis.

Henken FE, Wilting SM, Overmeer RM, van Rietschoten JG, Nygren AO, Errami A, Schouten JP, Meijer CJ, Snijders PJ, Steenbergen RD.

Br J Cancer. 2007 Nov 19;97(10):1457-64. Epub 2007 Oct 30.

PMID:
17971771
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

DNA methylation analysis in liquid-based cytology for cervical cancer screening.

Apostolidou S, Hadwin R, Burnell M, Jones A, Baff D, Pyndiah N, Mould T, Jacobs IJ, Beddows S, Kocjan G, Widschwendter M.

Int J Cancer. 2009 Dec 15;125(12):2995-3002. doi: 10.1002/ijc.24745.

PMID:
19609949
[PubMed - indexed for MEDLINE]
7.

Identification of novel DNA methylation markers in cervical cancer.

Lai HC, Lin YW, Huang TH, Yan P, Huang RL, Wang HC, Liu J, Chan MW, Chu TY, Sun CA, Chang CC, Yu MH.

Int J Cancer. 2008 Jul 1;123(1):161-7. doi: 10.1002/ijc.23519.

PMID:
18398837
[PubMed - indexed for MEDLINE]
8.

A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients.

Eijsink JJ, Lendvai Á, Deregowski V, Klip HG, Verpooten G, Dehaspe L, de Bock GH, Hollema H, van Criekinge W, Schuuring E, van der Zee AG, Wisman GB.

Int J Cancer. 2012 Apr 15;130(8):1861-9. doi: 10.1002/ijc.26326. Epub 2012 Feb 13.

PMID:
21796628
[PubMed - indexed for MEDLINE]
9.

Development of a multiplex methylation-specific PCR as candidate triage test for women with an HPV-positive cervical scrape.

Snellenberg S, De Strooper LM, Hesselink AT, Meijer CJ, Snijders PJ, Heideman DA, Steenbergen RD.

BMC Cancer. 2012 Nov 23;12:551. doi: 10.1186/1471-2407-12-551.

PMID:
23176198
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens.

Kim JH, Choi YD, Lee JS, Lee JH, Nam JH, Choi C.

Gynecol Oncol. 2010 Jan;116(1):99-104. doi: 10.1016/j.ygyno.2009.09.032.

PMID:
19836067
[PubMed - indexed for MEDLINE]
11.

Detection of hypermethylated genes in women with and without cervical neoplasia.

Feng Q, Balasubramanian A, Hawes SE, Toure P, Sow PS, Dem A, Dembele B, Critchlow CW, Xi L, Lu H, McIntosh MW, Young AM, Kiviat NB.

J Natl Cancer Inst. 2005 Feb 16;97(4):273-82.

PMID:
15713962
[PubMed - indexed for MEDLINE]
Free Article
12.

Hypermethylation of two consecutive tumor suppressor genes, BLU and RASSF1A, located at 3p21.3 in cervical neoplasias.

Lai HC, Lin YW, Chang CC, Wang HC, Chu TW, Yu MH, Chu TY.

Gynecol Oncol. 2007 Mar;104(3):629-35. Epub 2006 Nov 13.

PMID:
17097722
[PubMed - indexed for MEDLINE]
13.

Persistent high-risk human papillomavirus infections and other end-point markers of progressive cervical disease among women prospectively followed up in the New Independent States of the Former Soviet Union and the Latin American Screening study cohorts.

Syrjänen K, Shabalova I, Naud P, Kozachenko V, Derchain S, Zakharchenko S, Roteli-Martins C, Nerovjna R, Longatto-Filho A, Kljukina L, Tatti S, Branovskaja M, Hammes LS, Branca M, Grunjberga V, Erzen M, Sarian LO, Juschenko A, Costa S, Podistov J, Syrjänen S; New Independent States of the Former Soviet Union and the Latin American Screening Study Research Groups.

Int J Gynecol Cancer. 2009 Jul;19(5):934-42. doi: 10.1111/IGC.0b013e3181a834fe.

PMID:
19574788
[PubMed - indexed for MEDLINE]
14.

Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women.

Hesselink AT, Heideman DA, Steenbergen RD, Coupé VM, Overmeer RM, Rijkaart D, Berkhof J, Meijer CJ, Snijders PJ.

Clin Cancer Res. 2011 Apr 15;17(8):2459-65. doi: 10.1158/1078-0432.CCR-10-2548. Epub 2011 Mar 9.

PMID:
21389098
[PubMed - indexed for MEDLINE]
Free Article
15.

Aberrant promoter methylation can be useful as a marker of recurrent disease in patients with cervical intraepithelial neoplasia grade III.

Terra AP, Murta EF, Maluf PJ, Caballero OL, Brait M, Adad SJ.

Tumori. 2007 Nov-Dec;93(6):572-9.

PMID:
18338492
[PubMed - indexed for MEDLINE]
16.

Cyclin A1 promoter hypermethylation in human papillomavirus-associated cervical cancer.

Kitkumthorn N, Yanatatsanajit P, Kiatpongsan S, Phokaew C, Triratanachat S, Trivijitsilp P, Termrungruanglert W, Tresukosol D, Niruthisard S, Mutirangura A.

BMC Cancer. 2006 Mar 8;6:55.

PMID:
16524460
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Human papillomavirus types 16 and 18 mRNA levels and not DNA levels may be associated with advancing stages of cervical cancer.

Gnanamony M, Peedicayil A, Subhashini J, Ram TS, Christopher S, Gravitt P, Abraham P.

Int J Gynecol Cancer. 2009 Nov;19(8):1415-20. doi: 10.1111/IGC.0b013e3181b62e05.

PMID:
20009900
[PubMed - indexed for MEDLINE]
18.

Population-based case-control study on DAPK1, RAR-β2 and MGMT methylation in liquid-based cytology.

Sun LL, Cao DY, Yang JX, Li H, Zhou XR, Song ZQ, Cheng XM, Chen J, Shen K.

Arch Gynecol Obstet. 2012 May;285(5):1433-9. doi: 10.1007/s00404-011-2149-6. Epub 2011 Nov 25.

PMID:
22116316
[PubMed - indexed for MEDLINE]
19.

Folate status and aberrant DNA methylation are associated with HPV infection and cervical pathogenesis.

Flatley JE, McNeir K, Balasubramani L, Tidy J, Stuart EL, Young TA, Powers HJ.

Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2782-9. doi: 10.1158/1055-9965.EPI-09-0493. Epub 2009 Sep 15.

PMID:
19755648
[PubMed - indexed for MEDLINE]
Free Article
20.

Promoter methylation analysis of WNT/β-catenin signaling pathway regulators to detect adenocarcinoma or its precursor lesion of the cervix.

van der Meide WF, Snellenberg S, Meijer CJ, Baalbergen A, Helmerhorst TJ, van der Sluis WB, Snijders PJ, Steenbergen RD.

Gynecol Oncol. 2011 Oct;123(1):116-22. doi: 10.1016/j.ygyno.2011.06.015. Epub 2011 Jul 2.

PMID:
21726894
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk